z-logo
open-access-imgOpen Access
Long hidden sepsis subgroup may benefit from immune therapy
Author(s) -
Mark Tidswell
Publication year - 2018
Publication title -
journal of emergency and critical care medicine
Language(s) - English
Resource type - Journals
ISSN - 2521-3563
DOI - 10.21037/jeccm.2018.12.03
Subject(s) - sepsis , medicine , inflammation , intensive care medicine , innate immune system , immune system , clinical trial , systemic inflammatory response syndrome , immunology , mortality rate , bioinformatics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom